cardiovascular health
The ARTIS Ventures-led raise brings Eko's total raise to $27.8 million.
The Belgium-based company's app can render heart rhythm irregularity readings in roughly 60 seconds.
The startup is looking to buff up its sales teams with the Series B funding.
The daily-use digital intervention yielded "clinically meaningful" improvement in blood pressure among 172 users.
AliveCor’s KardiaMobile five times more effective at detecting heart arrhythmia than standard tests…
Researchers have now called for the device to be incorporated into standard care in A&E departments.
In addition, Apple shared some snippets of the validation data it shared with the FDA.
Endotronix lands $45 million to launch its Cordella Heart Failure System and further development of its Cordella Pulmonary Artery Sensory system.